top of page
WHAT WE DO
Our Pipeline
Dermatology products are challenging to develop and manufacture with complexities arising from formulation & process development, stability and scale up. In addition, a majority of the dermatology products require expensive clinical studies, which act as a barrier to entry for a lot of companies. Such products offer a niche market opportunity for Solaris Pharma Corporation.
Solaris Pharma Corporation benefits from its technical expertise in the development of specialized generic & branded dermatology products. With its committed and well-trained scientific personnel, Solaris Pharma Corporation is currently developing several topical & transdermal products, which are in different stages of development.


The topical dosage forms that are being developed at our facility include:
Topical Dosage Forms | |
---|---|
Ointments | |
Gels | |
Creams | |
Lotions | |
Solutions | |
Sprays | |
Foams |
These target several indications such as:
Target Several Indications | |
---|---|
Pain | |
Acne | |
Psoriasis | |
Atopic Dermatitis | |
Antifungal | |
Rosacea |
bottom of page